Congressional Research Service Reports - 206 Matching Results
Search Results
- Governmental Drug Testing Programs: Legal and Constitutional Developments
- This report examines the current state of constitutional law on the subject of governmentally mandated drug testing in employment and of students in the public schools, which is followed by a brief review of federal drug-free workplace programs presently in effect.
- Haiti: Efforts to Restore President Aristide, 1991-1994
- This report tracks the efforts to restore to office President Aristide of Haiti between the years 1991-1994. During this period, the main U.S. foreign policy concern was the restoration of the democratic process to Haiti. Closely related to this was the issue of Haitians attempting to flee to the United States by boat. Congressional concerns focused on human rights, Haitian migration, socioeconomic conditions, and drug trafficking.
- Heroin: Legalization for Medical Use
- This report discusses the limited legalization of diacetylmorphine (heroin) for use in the medical treatment of intractable pain. The report attempts to present pros and cons on the issue as well as information on pending legislation. The report also provides a comparison of heroin's analgesic qualities to those of currently available and equivalent pharmaceutical alternatives.
- Heroin Trafficking in the United States
- This report provides an overview of heroin trafficking into and within the United States. It includes a discussion of links between the trafficking of heroin and the illicit movement of related substances such as controlled prescription drugs and synthetic drugs like fentanyl. The report also outlines existing U.S. efforts to combat heroin trafficking and possible congressional considerations going forward.
- High Intensity Drug Trafficking Areas (HIDTA) Program
- This report provides an overview of the High Intensity Drug Trafficking Areas (HIDTA) program, including how areas are designated as part of a HIDTA, and program coordination and funding. It also examines issues that policymakers may consider as they debate the future of the program: whether the county is still an appropriate unit of inclusion, whether the criteria remain adequate, whether the program is effective, whether its tangential effects can be measured, whether the current bounds on funds are still appropriate, and which federal entity may be best suited to administer the program.
- Hurricanes Katrina
- The Department of Health and Human Services’ Substance Abuse & Mental Health Services Administration (SAMHSA) has three primary mechanisms of providing federal funding to meet the mental health and substance abuse prevention needs of victims of recent hurricanes: the Crisis Counseling Assistance and Training Program (CCP), SAMHSA Emergency Response Grants (SERG), and supplemental appropriations. CCPs may be of interest to Congress, as questions have arisen regarding their appropriate scope and duration following two previous large-scale emergency situations (the Oklahoma City bombing, and the September 11, 2001 terrorist attacks). SERG may also be of interest, as Congress may consider amending or suspending existing law to enhance the availability of grant money. Congress has already passed two supplemental appropriations . This may lead Congress to consider a range of oversight options. This report will be updated as needed.
- Illicit Drugs and the Terrorist Threat: Causal Links and Implications for Domestic Drug Control Policy
- The international traffic in illicit drugs contributes to terrorist risk through at least five mechanisms: supplying cash, creating chaos and instability, supporting corruption, providing “cover” and sustaining common infrastructures for illicit activity, and competing for law enforcement and intelligence attention. Of these, cash and chaos are likely to be the two most important.
- Increase in Illicit Fentanyl Overdose Deaths
- This report discusses fentanyl, a synthetic opioid that is 50-100 times more potent than morphine. The steep increase in overdose deaths involving fentanyl is seen as a "new chapter" in the opioid epidemic. Topics covered include the rise of fentanyl overdoses, availability of fentanyl, and policy considerations.
- International Convention Against Doping in Sport: Issues for Congress
- The International Convention Against Doping in Sport seeks to harmonize anti-doping commitments for non-professional sports at the international level. Issues that may continue to arise as policymakers evaluate the Convention include its relationship to anti-doping regulations in professional sports and the legitimacy and effectiveness of current international anti-doping activities.
- International Convention Against Doping in Sport: Issues for Congress
- The International Convention Against Doping in Sport seeks to harmonize anti-doping commitments for non-professional sports at the international level. Issues that could arise as the Senate considers the Convention include its relationship to anti-doping regulations in professional sports, potential consequences that non-ratification could pose to the United States, and the legitimacy and effectiveness of current international anti-doping activities.
- International Convention Against Doping in Sport: Issues for Congress
- The International Convention Against Doping in Sport seeks to harmonize anti-doping commitments for non-professional sports at the international level. This Convention was adopted by the United Nations Educational, Scientific, and Cultural Organization (UNESCO) in 2005 and entered in force on February 1, 2007. Issues that could arise as the Senate considers the treaty include its relationship to anti-doping regulations in professional sports, potential consequences that non-ratification could pose to the United States, and the legitimacy and effectiveness of current international anti-doping activities.
- International Drug Control Policy
- This report discusses the scope of the international drug control problem, current measures in place. It includes sections that discuss: the global scope of the problem, strategic guidance, overall U.S. drug control funding, U.S. assistance for international counternarcotics programs, policy issues, and conclusions.
- International Drug Control Policy
- This report provides an overview of U.S. international drug control policy. It describes major international counternarcotics initiatives and evaluates the broad array of U.S. drug control policy tools currently in use. The report also considers alternative counterdrug policy approaches to current initiatives and raises several counterdrug policy issues and considerations for policy makers.
- International Drug Control Policy
- This report provides an overview of U.S. international drug control policy. It describes major international counternarcotics initiatives and evaluates the broad array of U.S. drug control policy tools currently in use. The report also considers alternative counterdrug policy approaches to international drug control initiatives and raises several counterdrug policy issues and considerations for policy makers.
- International Drug Control Policy
- This report provides an overview of U.S. international drug control policy. It describes major international counternarcotics initiatives and evaluates the broad array of U.S. drug control policy tools currently in use. The report also considers alternative counterdrug policy approaches to current initiatives and raises several counterdrug policy issues and considerations for policy makers.
- International Drug Control Policy
- This report provides an overview of U.S. international drug control policy. It describes major international counternarcotics initiatives and evaluates the broad array of U.S. drug control policy tools currently in use. The report also considers alternative counterdrug policy approaches to current initiatives and raises several counterdrug policy issues and considerations for policy makers.
- International Drug Control Policy: Background and U.S. Responses
- The report provides background information on drug cultivation, drug trafficking and the consequences of drug trade. This report discusses challenges created by the global illegal drug trade, including: undermining political and regional stability, bolstering the role and capabilities of transnational criminal organizations in the drug trade, and the burden caused by drug use an addition on local communities and economic development. In addition, this report discusses U.S. policy efforts to thwart illegal drug trade.
- International Drug Control Policy: Background and U.S. Responses
- The global illegal drug trade represents a multi-dimensional challenge that has implications for U.S. national interests as well as the international community. This report discusses U.S. international policy frameworks and approaches in response to the issue.
- International Drug Control Policy: Background and U.S. Responses
- This report discusses challenges created by the global illegal drug trade, including: undermining political and regional stability, bolstering the role and capabilities of transnational criminal organizations in the drug trade, and the burden caused by drug use an addition on local communities and economic development. In addition, this report discusses U.S. policy efforts to thwart illegal drug trade.
- International Drug Trade and U.S. Foreign Policy
- This report details the U.S. international narcotics policies and how these policies may affect foreign policy interests. It also discusses major foreign policy initiatives with Latin American and Middle Eastern countries, as well as the Bush Administration's anti-drug strategy.
- Legal Authorities Under the Controlled Substances Act to Combat the Opioid Crisis
- This report discusses legal authorities available to the federal government under the Controlled Substances Act (CSA) that could be used to combat the opioid epidemic. The report then examines DEA initiatives and actions taken, pursuant to its legal authorities under the CSA, which specifically target the abuse of opioids. It concludes by discussing selected opioid-related legislative proposals in the 115th Congress that would amend the CSA.
- Legal Issues Relating to the Disposal of Dispensed Controlled Substances
- Prescription drug abuse is the second-most common form of illicit drug abuse among teenagers in the United States, trailing only marijuana use. Prescription drug abuse has become a particular concern amongst federal policymakers. This report discusses this issue, including related pieces of legislation such as the Controlled Substances Act, the Secure and Responsible Drug Disposal Act of 2010, and the proper way to dispose of controlled substances.
- Legal Issues Relating to the Disposal of Dispensed Controlled Substances
- This report describes an issue that is the fastest-growing drug problem in the country -- the intentional use of prescription drugs for non-medical purposes. It is the second-most common form of illicit drug abuse among teenagers in the United States behind marijuana use. Several bills have been introduced in the 111th Congress that would create a legal framework governing disposal of controlled substances that have been dispensed to patients.
- Legislation Relating to the Control of Drug Abuse, 92nd Congress
- This report
- A Low Carbon Fuel Standard: State and Federal Legislation and Regulations
- This report analyzes the draft California standards, and discusses how those standards might work. Next, the report analyzes federal Low Carbon Fuel Standard (LCFS) legislation proposed in the 110th Congress. Finally, the report analyzes what effects an LCFS might have on state and national fuel supplies.
- Marijuana: Medical and Retail -- An Abbreviated View of Selected Legal Issues
- This report discusses the federal law regarding marijuana that is classified as a Schedule I Controlled Substance. The federal Controlled Substances Act (CSA) outlaws the possession, cultivation, or distribution of marijuana except for authorized research.
- Marijuana: Medical and Retail -- Selected Legal Issues
- This report discusses state medical marijuana laws that grants registered patients, their doctors, and providers immunity from the consequences of state law.
- Marijuana: Medical and Retail-- Selected Legal Issues
- This report discusses the federal Controlled Substances Act (CSA) as it pertains to marijuana. The CSA outlaws the possession, cultivation, and distribution of marijuana except for authorized research. More than 20 states have regulatory schemes that allow possession, cultivation, and distribution of marijuana for medicinal purposes. The U.S. Constitution's Supremacy Clause preempts any state law that conflicts with federal law.
- The Marijuana Policy Gap and the Path Forward
- This report describes the federal response to state actions to decriminalize or legalize marijuana. It includes general information about marajuana and trends among states, the federal response, a discussion of the implications of legalization, and selected issues.
- Medical Marijuana: Review and Analysis of Federal and State Policies
- This report discusses the issue facing Congress on whether to continue to support the executive branch’s prosecution of medical marijuana patients and their providers, in accordance with marijuana’s status as a Schedule I drug under the Controlled Substances Act, or whether to relax federal marijuana prohibition enough to permit the medical use of botanical cannabis products by seriously ill persons, especially in states that have created medical marijuana programs under state law.
- Mérida Initiative for Mexico and Central America: Funding and Policy Issues
- In October 2007, the United States and Mexico announced the Mérida Initiative, a three-year program of U.S. assistance to Mexico and Central America to combat drug trafficking, gangs, and organized crime. This report provides an overview and discussion of the funding provided for Mérida, and presents several issues that Congress may consider as it oversees implementation of the Initiative and shapes its future direction.
- Mérida Initiative for Mexico and Central America: Funding and Policy Issues
- In October 2007, the United States and Mexico announced the Mérida Initiative, a three-year proposal for $1.4 billion in U.S. assistance to Mexico and Central America aimed at combating drug trafficking, gangs, and organized crime. This report provides an overview and discussion of the funding provided for Mérida, and presents several issues that Congress may consider as it oversees implementation of the Initiative.
- Merida Initiative: Proposed U.S. Anticrime and Counterdrug Assistance for Mexico and Central America
- In October 2007, the United States and Mexico announced the Mérida Initiative, a multi-year proposal for $1.4 billion in U.S. assistance to Mexico and Central America aimed at combating drug trafficking, gangs, and organized crime. This report outlines the various appropriations and other foreign aid measures outlined in the Mérida Initiative and what future actions regarding this ongoing effort will include.
- Merida Initiative: Proposed U.S. Anticrime and Counterdrug Assistance for Mexico and Central America
- In October 2007, the United States and Mexico announced the Mérida Initiative, a multi-year proposal for $1.4 billion in U.S. assistance to Mexico and Central America aimed at combating drug trafficking, gangs, and organized crime. This report outlines the various appropriations and other foreign aid measures outlined in the Mérida Initiative and what future actions regarding this ongoing effort will include.
- Methadone Maintenance Treatment for Heroin Addiction
- This report discusses methadone treatment centers for heroin addicts and research regarding their successes and limitations.
- Methamphetamine: Legislation and Issues in the 109th Congress
- This report provides a brief overview of illicit methamphetamine (MA) abuse, production, trafficking, the federal methamphetamine-specific programs, and anti-MA legislation introduced in the 109th Congress. MA abuse has implications for public health, child welfare, crime and public safety, border security, and international relations.
- Methamphetamine: Legislation and Issues in the 109th Congress
- Illicit methamphetamine (MA) production and use are longstanding and severe problems in some states. This report provides a brief overview of MA abuse, production, trafficking, and of the federal methamphetamine-specific programs, and legislation that is being actively considered by the 109th Congress. This report will be updated to reflect future legislative activity.
- Mexican Drug Certification Issues: U.S. Congressional Action, 1986-1998
- No Description Available.
- Mexican Drug Certification Issues: U.S. Congressional Action, 1986-2001
- No Description Available.
- Mexican Drug Certification Issues: U.S. Congressional Action, 1986-2002
- No Description Available.
- Mexico-U.S. Relations: Issues for Congress
- This report explores the relationship between the United States and Mexico in terms of trade, drug trafficking, and cooperative disease control and management. Specifically, the report discusses the Mérida Initiative, the trade dispute involving the implementation of NAFTA trucking provisions, Secretary of State Clinton's March 2009 visit to Mexico, and the April 2009 outbreak of the H1N1 "swine flu" virus.
- Mexico's Counter-Narcotics Efforts under Fox, December 2000 to April 2002
- No Description Available.
- Mexico's Counter-Narcotics Efforts under Fox, December 2000 to October 2004
- No Description Available.
- Mexico's Counter-Narcotics Efforts under Zedillo and Fox, December 1994-March 2001
- No Description Available.
- Mexico's Counter-Narcotics Efforts Under Zedillo, December 1994 to March 1998
- No Description Available.
- Narcotics Certification of Drug Producing Trafficking Nations: Questions and Answers
- No Description Available.
- National Minimum Drinking Age: Provisions and Analysis
- No Description Available.
- No-fault Eviction of Public Housing Tenants for Illegal Drug Use: A Legal Analysis of Department of Housing and Urban Development v. Rucker
- No Description Available.
- The Opioid Epidemic and Federal Efforts to Address It: Frequently Asked Questions
- This report answers common questions that have arisen as drug overdose deaths in the United States continue to increase. It does not provide a comprehensive overview of opioid abuse as a public health or criminal justice issue. The report is divided into the following sections: Overview of Opioid Abuse; Overview of Opioid Supply; Select Federal Agencies and Programs that Address Opioid Abuse; Recent Legislation; and Opioid Abuse and State Policies.
- The Opioid Epidemic and the Food and Drug Administration: Legal Authorities and Recent Agency Action
- This report focuses on the U.S. Food and Drug Administration (FDA) as a key player in federal efforts to curb the opioid epidemic. It provides an overview of FDA's role in approving new prescription drugs, including challenges of approval and regulation of opioid products; addresses FDA's multifaceted approach in responding, including recent agency action; and concludes with a discussion of selected opioid-related legislation in the 115th Congress.